MN Wealth Advisors
VRTX icon

MN Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

MN Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.64M Buy
3,129
+31
+1% +$15.9K 0.66% 27
2026
Q2 		$1.54M Sell
3,098
-59
-2% -$26.1K 0.66% 27
2026
Q1 		$1.41M Buy
3,157
+7
+0.2% +$3.26K 0.69% 28
2025
Q4 		$1.43M Buy
3,150
+266
+9% +$115K 0.72% 26
2025
Q3 		$1.13M Buy
2,884
+476
+20% +$199K 0.6% 35
2025
Q2 		$1.07M Sell
2,408
-16
-0.7% -$7.37K 0.62% 38
2025
Q1 		$1.18M Sell
2,424
-539
-18% -$251K 0.69% 38
2024
Q4 		$1.19M Buy
2,963
+235
+9% +$109K 0.67% 34
2024
Q3 		$1.27M Buy
2,728
+65
+2% +$31.2K 0.72% 31
2024
Q2 		$1.25M Buy
2,663
+33
+1% +$14.3K 0.72% 31
2024
Q1 		$1.1M Hold
2,630
– – 0.68% 32
2023
Q4 		$1.07M Buy
+2,630
New +$972K 0.74% 32

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Provident Investment Management
Provident Investment Management Novi, Michigan $999M AUM 19.45% 1-Year Est. Return

MN Wealth Advisors's VRTX Position: Q3 2026 in Review

MN Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 1% in Q3 2026, buying an estimated $15.9K and bringing the position to 3,129 shares worth $1.64M. The position accounts for 0.66% of the portfolio, ranked #27.

MN Wealth Advisors first reported a position in VRTX in Q4 2023 and has held it in 12 quarters since. 478 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • MN Wealth Advisors held 3,129 shares of Vertex Pharmaceuticals worth $1.64M as of Q3 2026.
  • MN Wealth Advisors bought 31 Vertex Pharmaceuticals shares in Q3 2026, an estimated $15.9K.
  • Vertex Pharmaceuticals made up 0.66% of MN Wealth Advisors's portfolio in Q3 2026, its #27 holding.
  • MN Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • 478 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on MN Wealth Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.